期刊文献+

慢性心力衰竭患者血清结缔组织生长因子水平的变化

Changes of serum conective tissue growth factor levels in patients with chronic heart failure
原文传递
导出
摘要 目的研究慢性心力衰竭(CHF)患者血清结缔组织生长因子(CTGF)的变化及临床意义。方法测定105例CHF患者血清CTGF含量及左心室射血分数(LVEF)、左心室质量指数(LVMI)变化,进行相关分析,并选取68例健康人做为对照组。结果CHF患者血清CTGF水平均显著高于对照组(P〈0.01);血清CTGF升高水平与心力衰竭严重程度相平行;血清CTGF水平与LVEF呈负相关,与LVMI、心功能分级呈正相关。结论血清CTGF参与了CHF的病理生理过程,血清CTGF水平可作为诊断及判断心力衰竭严重程度的生物学指标。 Objective To study the changes of serum connective tissue growth factor (CTGF) levels in patients with chronic heart failure (CHF) and its clinical implications. Methods The serum CTGF levels and the left ventricular ejection fraction( LVEF), left ventricular mass index(LVMI) of 105 patients with CHF and 68 control subjects were measured and analyzed. Results The serum CTGF level in patients with CHF was significantly higher than that in the control group (P 〈 0.01 ) ; The increased level of serum CTGF was parallelled with the severity of heart failure; The serum CTGF level was nega- tively correlated with LVEF, and positively correlated with LVMI and cardiac function classification. Conclusions Serum CTGF participate in the pathological and physiological process of CHF, so serum CTGF level can be used as biological index of diagnosis and judgement of the severity of heart failure.
出处 《中国实用医刊》 2014年第13期30-31,共2页 Chinese Journal of Practical Medicine
关键词 心力衰竭 结缔组织生长因子 Heart failure Conective tissue growth factor
  • 相关文献

参考文献9

二级参考文献59

  • 1石向东,李志梁,吴宏超,吕永恒,王同汉,傅强,徐春生,唐朝枢.尾加压素Ⅱ促血管内皮细胞分泌肾上腺髓质素的作用[J].中华心血管病杂志,2005,33(9):836-839. 被引量:12
  • 2刘欣,康毅,贺慧杰,赵秀兰,刘恩桥.糖尿病大鼠心肌TGF-β_1表达及细胞凋亡的实验研究[J].中国病理生理杂志,2007,23(2):303-306. 被引量:16
  • 3李昌繁,江时森.心力衰竭动物模型的研究进展[J].医学研究生学报,2007,20(5):532-534. 被引量:30
  • 4PERTICONE F,MAIO R,CERAVOLO R,et al.Relationship between left ventricular mass and endotheliamdependent vasedilation in never-treated hypertensive patients[J].Circulation,1999,99 (15):1991-1996.
  • 5CHEUNG B M,LEUNG R,MAN Y B,et al.Plasma concentration of urotensin Ⅱ is raised in hypetension[J].J Hypertens,2004,22 (7):1341-1344.
  • 6TZANIDIS A,HANNAN R D,THOMAS W G,et al.Direct actions of urotensin Ⅱ on the heart:implications for cardiac fibrosis and hypertrophy[J].Circ Res,2003,93 (3):246-253.
  • 7LAPP H,BOERRIGTER G,COSTELLO-BOERRIGTER L C,et al.Elevated plasma haman uroteasin-Ⅱ-like immunoreactivity in ischemic cardiomyopathy[J].Int J Cardiol,2004,94 (1):93-97.
  • 8ZHANG Y,LI J,CAO J,et al.Effect of chronic hypoxia on contents of urotensin Ⅱ and its functional receptors in rat myocardium[J].Heart Vessels,2002,16 (2):64-68.
  • 9RUSSELL F D,MOLENAAR P,O'BRIEN D M.Cardiostimulant effects of urotensin-Ⅱ in human heart in vitro[J].Br J Pharmacol,2001,132 (1):5-9.
  • 10TSURUDA T,BURNETT J C J R,Adrenomedullin:an autocrine/paracrine factor for eardiorenal protection[J].Circ Res,2002,90 (6):625-627.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部